Cytokine genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2726-2733

  Weng, Ken Pen ^a,b,c   Ho, Tsyr Yuh ^d   Chiao, Ya Hui ^e,f   Cheng, Jiin Tsuey ^f   Hsieh, Kai Sheng ^a   Huang, Shih Hui ^b   Ou, Shan F ^d   Liu, Kai His ^d   Hsu, Ching Ju ^a   Lu, Pei Jung ^g   Hsiao, Michael ^h   Ger, Luo Ping ^e,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c SHU ZEN JUNIOR COLLEGE OF MEDICINE AND MANAGEMENT   (Taiwan)

^d ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^e KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^g NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^h GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Cytokines; Gene dosage effect; Kawasaki disease; Polymorphisms

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AGE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ADULT; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; MIDDLE AGED; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TAIWAN;

EID: 78649711923     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0542     Document Type: Article

References (49)

1. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364: 533-544.
2. Huang SM, Weng KP, Chang JS, Lee WY, Huang SH, Hsieh KS. Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease: A pilot study. Circ J 2008; 72: 1583-1587.
3. Takatsuki S, Ito Y, Takeuchi D, Hoshida H, Nakayama T, Matsuura H, et al. IVIG reduced vascular oxidative stress in patients with Kawasaki disease. Circ J 2009; 73: 1315-1318.
4. Huang WC, Huang LM, Chang IS, Chang LY, Chiang BL, Chen PJ, et al, the Kawasaki Disease Research Group. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 2009; 123: e401-e405.
5. Yanagawa H, Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K. Incidence of Kawasaki disease in Japan: The nationwide surveys of 1999-2002. Pediatr Int 2006; 48: 356-361.
6. Park YW, Han JW, Park IS, Kim CH, Yun YS, Cha SH, et al. Epidemiologic picture of Kawasaki disease in Korea, 2000-2002. Pediatr Int 2005; 47: 382-387.
7. Morens DM, Anderson LJ, Hurwitz ES. National surveillance of Kawasaki disease. Pediatrics 1980; 65: 21-25.
8. Salo E, Pelkonen P. Circulating interleukin-1 in patients with Kawasaki disease. N Engl J Med 1988; 319: 1670-1671.
9. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 1990; 56: 29-36.
10. Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992; 121: 924-926.
11. Kim DS, Lee HK, Noh GW, Lee SI, Lee KY. Increased serum interleukin-10 level in Kawasaki disease. Yonsei Med J 1996; 37: 125-130.
12. Hirao J, Hibi S, Andoh T, Ichimura T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 1997; 112: 152-156.
13. Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009; 20: 43-59.
14. Dominici R, Cattaneo M, Malferrari G, Archi D, Mariani C, Grimaldi LM, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 2002; 54: 82-86.
15. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006; 15: 519-529.
16. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998; 47: 195-198.
17. Wu SF, Chang JS, Wan L, Tsai CH, Tsai FJ. Association of IL-1Ra gene polymorphism, but no association of IL-1beta and IL-4 gene polymorphisms, with Kawasaki disease. J Clin Lab Anal 2005; 19: 99-102.
18. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 2(Suppl): 74-78.
19. Burns JC, Shimizu C, Shike H, Newburger JW, Sundel PP, Baker AL, et al. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun 2005; 6: 438-444.
20. Buchs N, Silvestri T, di Giovine FS, Chabaud M, Vannier E, Duff GW, et al. IL-4 VNTR gene polymorphism in chronic polyarthritis: The rare allele is associated with protection against destruction. Rheumatology 2000; 39: 1126-1131.
21. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
22. Lu AZ, Wang LB, Zhang MZ, Zhang XB. Association of interleukin 8 single nucleotide polymorphisms with the susceptibility to respiratory syncytial virus infection. Zhonghua Er Ke Za Zhi 2007; 45: 100-104.
23. Weng KP, Hsieh KS, Hwang YT, Huang SH, Lai TJ, Yuh YS, et al. IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease. Circ J 2010; 74: 983-989.
24. Claudino M, Trombone AP, Cardoso CR, Ferreira SB Jr, Martins W Jr, Assis GF, et al. The broad effects of the functional IL-10 promoter-592 polymorphism: Modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J Leukoc Biol 2008; 84: 1565-1573.
25. Chien YH, Chang KW, Yang YH, Lu MY, Lin YT, Chiang BL. Association between levels of TNF-alpha and TNF-alpha promoter -308 A/A polymorphism in children with Kawasaki disease. J Formos Med Assoc 2003; 102: 147-150.
26. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8: 93-97.
27. Cheung YF, Huang GY, Chen SB, Liu XQ, Xi L, Liang XC, et al. Inflammatory gene polymorphisms and susceptibility to kawasaki disease and its arterial sequelae. Pediatrics 2008; 122: e608-e614.
28. Hsueh KC, Lin YJ, Chang JS, Wan L, Tsai YH, Tsai CH, et al. Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease. J Korean Med 2009; 24: 438-442.
29. Huang FY, Chang TY, Chen MR, Lee HC, Chiu NC, Chi H, et al. The -590 C/T and 8375 A/G interleukin-4 polymorphisms are not associated with Kawasaki disease in Taiwanese children. Hum Immunol 2008; 69: 52-57.
30. Kamizono S, Yamada A, Higuchi T, Kato H, Itoh K. Analysis of tumor necrosis factor-a production and polymorphisms of the tumor necrosis factor-a gene in individuals with a history of Kawasaki disease. Pediatr Int 1999; 41: 341-345.
31. Quasney MW, Bronstein DE, Cantor RM, Cantor RM, Zhang Q, Shike H, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-a levels in children with Kawasaki disease. Pediatr Res 2001; 49: 686-690.
32. Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, et al. The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter. Zhonghua Er Ke Za Zhi 2003; 41: 598-602.
33. Jin HS, Kim HB, Kim BS, Lee JK, Seo EJ, Yoo HW, et al. The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease. Pediatr Res 2007; 61: 584-587.
34. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289-300.
35. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001; 29: 306-309.
36. Sohn MH, Hur MW, Kim DS. Interleukin 6 gene promoter polymorphism is not associated with Kawasaki disease. Genes Immun 2001; 2: 357-362.
37. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138-18144.
38. Asano T, Ogawa S. Expression of IL-8 in Kawasaki disease. Clin Exp Immunol 2000; 122: 514-519.
39. Hui-Yuen J, Duong TT, Yeung RSM. TNF-a is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 2006; 176: 6294-6301.
40. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 2003; 33: 469-475.
41. Hausmann EH, Hao SY, Pace JL, Parmely MJ. Transforming growth factor beta 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages. Infect Immun 1994; 62: 3625-3632.
42. Matsubara T, Umezawa Y, Tsuru S, Motohashi T, Yabuta K, Furukawa S. Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease. Scand J Rheumatol 1997; 26: 314-317.
43. Nakamura Y, Aso E, Yashiro M, Uehara R, Watanabe M, Oki I, et al. Mortality among persons with a history of kawasaki disease in Japan: Mortality among males with cardiac sequelae is significantly higher than that of the general population. Circ J 2008; 72: 134-138.
44. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 2009; 5: e1000319.
45. Breunis WB, Biezeveld MH, Geissler J, Ottenkamp J, Kuipers IM, Lam J, et al. Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum 2006; 54: 1588-1594.
46. Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, et al. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis 2005; 192: 344-349.
47. Biezeveld MH, Kuipers IM, Geissler J, Lam J, Ottenkamp JJ, Hack CE, et al. Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. Lancet 2003; 361: 1268-1270.
48. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008; 40: 35-42.
49. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet 2005; 366: 1315-1323.